Background and Purpose-Emerging evidence raises the possibility of an association between depression and stroke risk.
D
epression after stroke has long been recognized as a common condition with many negative effects. [1] [2] [3] [4] [5] Whether depression is an antecedent risk factor for stroke has not been extensively studied, and evidence of this association remains inconclusive. 6, 7 Because depression has been associated with increased rates of cardiovascular disease 8, 9 and mortality, 8, 10, 11 it raises the possibility that a similar relation may exist for cerebrovascular disease.
The relation between age, depression, and stroke has not been fully explored. However, substantial evidence has shown that depression is a common condition in the elderly 12 and that the incidence rates of stroke increase with age. 13 Because the incidence of both depression and stroke increases with age, we examined the association between antecedent depression symptoms and risk of stroke according to age.
The objective of the present study was to determine whether the presence of symptoms indicative of depression at baseline examination was associated with an increased risk of stroke/transient ischemic attack (TIA) in elderly and nonelderly participants.
Subjects and Methods

Study Sample
The Framingham Heart Study, an epidemiological study of cardiovascular disease including stroke, was established in 1948 as a longitudinal, community-based, population study. During 1948 to 1950, 5209 men and women (55% women), aged 28 to 62 years and representing a two-thirds sample of the town of Framingham, Mass, were enrolled in the study. Since the study's inception, surviving original cohort subjects have undergone regular biennial examinations. Beginning in 1971 to 1974, 5124 children of the original cohort and spouses (offspring cohort) enrolled in the study. Details of the study design, implementation, and criteria for diagnosis have been previously published. 14, 15 The sample for this study consisted of 918 attendees of the original cohort cycle 22 (1990 to 1992 ; mean age, 80 years) and 3202 attendees of the offspring cohort cycle 6 (1996 to 1998, mean age, 59 years) who were free of stroke at these examinations, had complete assessment of depressive symptoms (defined as at least 16ϩ items), and were available for follow-up of incident stroke/TIA. The Boston Medical Center institutional review board approved the study, and all participants provided informed consent.
Depressive Symptoms
Depressive symptoms were evaluated with the Center for Epidemiological Studies Depression scale (CES-D). 16 It was administered by a technician at cohort examination 22 (1990) and offspring examination 6 (1996) and is a 20-item scale documenting 4 factors: depressive affect, somatic complaints, positive affect, and interpersonal relations, with proven internal consistency, test-retest reliability, and construct validity. 16, 17 Scores on the CES-D range from 0 to 60, with higher scores indicating more symptoms of depression. According to CES-D guidelines, 16 scores of 0 to 15 were indicative of nondepression, and scores of 16 to 60 were indicative of depressive symptomatology.
Stroke Case Ascertainment
Because the primary outcome of our study was the occurrence of an initial cerebrovascular event, we included TIAs along with completed strokes. Stroke was defined as a focal neurological deficit of sudden or rapid onset that persisted for Ͼ24 hours, and TIA, as a focal neurological deficit that fully resolved in Ͻ24 hours. Continuous surveillance for cerebrovascular events included daily hospital monitoring, tracking of medical encounters, and examination of those with possible stroke symptoms. All events were adjudicated by a panel of at least 2 neurologists, and verification of stroke was available for 90% of stroke cases by imaging. Stroke occurrence and characteristics, including subtypes, were determined at the end of the acute phase of the stroke according to uniform criteria 18 and a standardized protocol. 19 
Statistical Analyses
Data from the original and offspring cohorts were pooled, and each subject contributed up to 8 years of follow-up from the baseline examination to the occurrence of stroke/TIA or censoring (at death, last examination, loss to follow-up, or 8 years). We considered 2 forms of the CES-D. First, we classified those with CES-D scores of at least 16 as indicative of depressive symptoms and those with a score 15 and below as not indicative of depressive symptoms. To substantiate increments of symptoms, we then used the continuous CES-D score to assess the risk of incident stroke/TIA associated with a 10-unit increase in CES-D. We used Cox proportional-hazards regression modeling to compare individuals with scores indicative of depressive symptoms with those with scores that were not indicative of depressive symptoms with respect to incident stroke/TIA and to estimate the hazard ratio (HR) associated with a 10-unit increase in CES-D score. Analyses were adjusted for age and sex and then additionally for components of the Framingham Stroke Risk Profile (FSRP), including blood pressure, diabetes, atrial fibrillation, cardiovascular disease, left ventricular hypertrophy on the ECG, and current smoking. 20 Because the CES-D per se does not diagnose clinical depression and the use of antidepressant medication may have an effect on symptoms, we performed a supplementary analysis wherein the definition of depression was expanded to include those taking antidepressants, even if their current depressive symptoms were below the cutoff point. Treatment for depression with antidepressants was documented at baseline examination. Antidepressants included treatment with selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, tricyclic agents, modified cyclics, and other miscellaneous medications classified as antidepressants.
Anticipating that there might be an interaction between age and the effect of depressive symptoms on stroke, we performed a test of interaction. The results of the test confirmed a significant interaction; thus, all subsequent analyses were performed separately by age groups (Ͻ65 years and 65ϩ years). All statistical analyses were performed with SAS software (version 8.1). 21 
Results
In this sample of 4120, the mean age was 63.9Ϯ12.3 years (nϭ2221 Ͻ65 years, nϭ1899 Ն65 years), 56% were women, and the majority were married. During the 8-year follow-up period, there were 228 cerebrovascular events, corresponding to 144 incident stroke cases (22 hemorrhagic, 122 ischemic) and 84 TIAs occurring in 102 men and 126 women. For the total sample at baseline, the mean CES-D score was 6.0Ϯ7.5, with 439 participants (10.7%) having a score of 16 or greater, indicative of depressive symptoms. Among those who had cerebrovascular events, 8.2% of ischemic strokes, 11.9% of TIAs, and 22.7% of hemorrhagic strokes had scores indicative of depressive symptoms at baseline examination. The distribution of characteristics within our sample at baseline, according to age and the presence or absence of depressive symptoms, are presented in Table 1 . Among participants Ͻ65 years, those with scores indicative of depressive symptoms were more likely to be women, to be current smokers, to consume less alcohol, to be unmarried, and to be taking antidepressant medications. Among participants 65 years and older, those with scores indicative of depressive symptoms were more likely to be women; to have cardiovascular
TABLE 1. Baseline Characteristics Classified by Age and CES-D Score
Age Ͻ65 y, nϭ2221
Age Ն65 y, nϭ1899 
001).
Men and women who were 65ϩ years and had CES-D scores indicative of depressive symptoms (Table 3 and Figure  2 ) were not at a significantly higher risk for stroke/TIA than those who were not depressed (HRϭ0. 
Discussion
In our community-based sample free of stroke or TIA at baseline, depressive symptoms were associated with a 4-fold increased risk of stroke/TIA in men and women Ͻ65 years but not in those 65ϩ years. With up to 8 years of follow-up, the association between depressive symptoms and risk of stroke/TIA was observed in those Ͻ65 years when depressive symptoms were treated as either a dichotomous or a continuous measure, when adjusted for traditional risk factors or for education, or when those taking antidepressants were included in the depressive symptom group. To our knowledge, this is the first community-based study to examine the elderly and nonelderly groups separately and to document the association between depressive symptoms and stroke risk in those Ͻ65 years.
During the past decade, the association between depressive symptoms and stroke has been examined in a number of studies, with varying conclusions. 7, 22, [23] [24] [25] [26] [27] [28] [29] Several studies reported that baseline depressive symptoms predicted the risk of incident stroke, 22, 23, 24 ischemic stroke, 7, 25 and stroke mortality. 24, 26 Other studies concluded that depressive symptoms were not associated with an increased risk of stroke in general 27, 28 or with nonfatal ischemic stroke or TIA. 29 We observed an association between antecedent depressive symptoms and risk of stroke/TIA but only in those below the age of 65 years. Our results are consistent with 2 previous studies documenting that baseline depression was not a risk 
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factor for stroke among individuals aged 60ϩ years 28 or 65ϩ years. 27 Our findings of an increased risk in the depressed nonelderly group support those of Gump et al, 24 who found an elevated risk of stroke among men aged 35 to 57 years; however, that study sample did not include either women or older men. In contrast, when Jonas and Mussolino 22 examined the risk of stroke in depressed individuals stratified by age (25 to 59 years and 60 to 74 years), a positive association was found in both age groups. However, the older age group in that study did not include individuals Ͼ74 years old, thus not inclusive of the oldest-old. Previous studies have shown an inconsistent relation between antidepressants and stroke risk. 30 -33 In our analysis, the inclusion of those taking antidepressants, even if their current depressive symptoms were below the cutoff point, did not significantly alter the risk of stroke/TIA associated with baseline depression in either age group. Also, the risk of stroke/TIA associated with baseline depression in those Ͻ65 years was not appreciably altered when those taking antidepressants were removed from the analysis.
Several mechanisms have been suggested in an attempt to explain the relation between antecedent depression and stroke. Multiple stroke risk factors may contribute to the association found between depressive symptoms and risk of stroke. However, when we examined the risk of stroke/TIA in the lowest quartile of the FSRP, a significant association remained (data not reported). Some genetic 34 and biological markers that have been implicated include increased levels of fibrinogen, 35, 36 platelet activation, 37, 38 and catecholamines. 39 More recently, inflammatory markers such as C-reactive protein have been suggested. 40, 41 The association between depression and the risk of stroke may also be attributed to poor adherence to prescribed medical regimens, including medication, diet, and exercise. Depression has been found to be associated with low physical activity, smoking, and indulging in behavioral patterns that may increase vascular risk. 22 The strengths of our investigation include its prospective design, duration of follow-up, large community-based sample, home/nursing home evaluations, and intensive stroke surveillance. Limitations include the lack of inclusion of diverse racial/ethnic groups and psychiatric documentation of depression and other mood disorders.
In conclusion, our study provides evidence supporting an association between depressive symptoms and an increased risk of stroke/TIA in individuals below the age of 65 years. Research is needed to determine the pathophysiological mechanisms leading to stroke in younger individuals who report depressive symptoms. Increased awareness of stroke risk in those exhibiting depressive symptoms may identify those who could benefit from primary stroke prevention.
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